77 related articles for article (PubMed ID: 17312678)
1. Assessment of inflammatory mediators in patients with generalized peritonitis.
Kikuchi M; Endo S; Inada K; Inoue Y; Wakabayashi G; Ishikura H; Tanaka T
J Med; 1999; 30(3-4):245-58. PubMed ID: 17312678
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
[TBL] [Abstract][Full Text] [Related]
3. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
[TBL] [Abstract][Full Text] [Related]
4. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.
Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066
[TBL] [Abstract][Full Text] [Related]
5. Serum phospholipase A2 in patients with multiple organ failure.
Nyman KM; Uhl W; Forsström J; Büchler M; Beger HG; Nevalainen TJ
J Surg Res; 1996 Jan; 60(1):7-14. PubMed ID: 8592435
[TBL] [Abstract][Full Text] [Related]
6. Relevance of serum phospholipase A2 assays to the assessment of septic shock.
Heath MF; Tighe D; Moss R; Bennett ED
Crit Care Med; 1990 Jul; 18(7):766-7. PubMed ID: 2364720
[No Abstract] [Full Text] [Related]
7. A multicenter study of phospholipase A2 in patients in intensive care units.
Uhl W; Beger HG; Hoffmann G; Hanisch E; Schild A; Waydhas C; Entholzner E; Müller K; Kellermann W; Vogeser M
J Am Coll Surg; 1995 Mar; 180(3):323-31. PubMed ID: 7874343
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines and nitric oxide in streptococcal toxic shock syndrome].
Martín MC; Gómez-Jiménez J; Esteban F; Saurí R; Mourelle MI; Salgado A
Med Clin (Barc); 1995 Apr; 104(12):458-60. PubMed ID: 7739283
[TBL] [Abstract][Full Text] [Related]
9. Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome.
Yamada Y; Endo S; Kasai T; Koike S; Takakuwa T; Inoue Y; Niimi M; Endo Y; Wakabayashi G; Inada K
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):92-104. PubMed ID: 9644723
[TBL] [Abstract][Full Text] [Related]
10. Functional modification of vascular endothelial cells by cytokines during septic shock.
Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
[TBL] [Abstract][Full Text] [Related]
11. The quantitative determination of endotoxin in plasma samples of septic patients with peritonitis using the chromogenic substrate and its correlation with the clinical course of peritonitis.
Nitsche D; Kriewitz M; Rossberg A; Hamelmann H
Prog Clin Biol Res; 1987; 231():417-29. PubMed ID: 3588634
[No Abstract] [Full Text] [Related]
12. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection.
Groeneveld AB; Tacx AN; Bossink AW; van Mierlo GJ; Hack CE
Clin Immunol; 2003 Feb; 106(2):106-15. PubMed ID: 12672401
[TBL] [Abstract][Full Text] [Related]
13. [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].
Wang CT; Ren HS; Jiang JJ; Zhang JC; Meng M; Yu JB; Chu YF; Ding M
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):421-4. PubMed ID: 19615135
[TBL] [Abstract][Full Text] [Related]
14. [A new pathophysiologic concept in chronic pancreatitis: tissue destruction induced via inflammatory mediators].
Friess H; Kashiwagi M; Uhl W; Schilling M; Zimmermann A; Büchler MW
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):431-6. PubMed ID: 14518291
[TBL] [Abstract][Full Text] [Related]
15. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.
Endo S; Inada K; Nakae H; Arakawa N; Takakuwa T; Yamada Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):347-56. PubMed ID: 8829774
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.
Vadas P
J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766
[TBL] [Abstract][Full Text] [Related]
18. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.
Vadas P; Hay JB
Can J Physiol Pharmacol; 1983 Jun; 61(6):561-6. PubMed ID: 6883208
[TBL] [Abstract][Full Text] [Related]
19. A predictive model for the clearance of soluble phospholipase A2 during septic shock.
Vadas P; Pruzanski W; Farewell V
J Lab Clin Med; 1991 Nov; 118(5):471-5. PubMed ID: 1940588
[TBL] [Abstract][Full Text] [Related]
20. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome.
Vadas P; Pruzanski W
Circ Shock; 1993 Feb; 39(2):160-7. PubMed ID: 8490995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
